Discontinuation report THALLOUS CHLORIDE TI 201 INJECTION

Last updated on 2021-06-05 History
Report ID 129592
Drug Identification Number Not Applicable/non applicable
Brand name THALLOUS CHLORIDE TI 201 INJECTION
Common or Proper name Thallous Chloride TI 201 Injection
Company Name GE HEALTHCARE CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) THALLIUM CHLORIDE
Strength(s) 37MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code V09GX
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-06-04
Actual discontinuation date 2021-06-04
Remaining supply date 2021-06-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-06-05 English Compare
v7 2021-06-04 French Compare
v6 2021-06-04 English Compare
v5 2020-12-04 French Compare
v4 2020-12-04 English Compare
v3 2020-12-04 French Compare
v2 2020-12-04 English Compare
v1 2020-12-04 English Compare